Quick Answer
USANA HEALTH SCIENCES INC reported Net Income Loss of $10.76 million for the year ending 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -74.4% in Net Income Loss from 2024 to 2025.
- This data is from USANA HEALTH SCIENCES INC's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $16.75 million | Q4 2013: $20.28 million | Q1 2014: $16.54 million | Q2 2014: $19.30 million | Q3 2014: $19.50 million | Q4 2014: $21.30 million | Q1 2015: $19.68 million | Q2 2015: $25.42 million | Q3 2015: $25.61 million | Q4 2015: $23.97 million | Q1 2016: $22.30 million | Q2 2016: $25.76 million | Q3 2016: $30.10 million | Q4 2016: $21.88 million | Q1 2017: $21.36 million | Q2 2017: $23.26 million | Q3 2017: $23.77 million | Q4 2017: -$5.85 million | Q1 2018: $28.95 million | Q2 2018: $33.91 million | Q3 2018: $31.04 million | Q4 2018: $32.33 million | Q1 2019: $24.17 million | Q2 2019: $21.38 million | Q3 2019: $24.22 million | Q4 2019: $30.75 million | Q1 2020: $26.55 million | Q2 2020: $27.98 million | Q3 2020: $30.51 million | Q1 2021: $30.62 million | Q2 2021: $38.23 million | Q3 2021: $27.33 million | Q1 2022: $22.47 million | Q2 2022: $19.16 million | Q3 2022: $14.93 million | Q1 2023: $18.38 million | Q2 2023: $17.29 million | Q3 2023: $11.35 million | Q1 2024: $16.54 million | Q2 2024: $10.43 million | Q3 2024: $10.61 million | Q1 2025: $9.40 million | Q2 2025: $9.66 million | Q3 2025: -$6.52 million.
- Over the full 17 years of available data (2009 to 2025), USANA HEALTH SCIENCES INC's Net Income Loss has declined by 67.9%.
- Historical annual values: Fiscal year 2025: $10.76 million | Fiscal year 2024: $42.03 million | Fiscal year 2023: $63.79 million | Fiscal year 2022: $69.35 million | Fiscal year 2021: $116.51 million | Fiscal year 2020: $124.66 million | Fiscal year 2019: $100.53 million | Fiscal year 2018: $126.22 million | Fiscal year 2017: $62.54 million | Fiscal year 2016: $100.04 million | Fiscal year 2015: $94.67 million | Fiscal year 2014: $76.64 million | Fiscal year 2013: $79.02 million | Fiscal year 2012: $66.43 million | Fiscal year 2011: $50.75 million | Fiscal year 2010: $45.65 million | Fiscal year 2009: $33.56 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: